Estimates of Hepatitis C Seroprevalence and Viremia in State Prison Populations in the United States
Background
Prior studies demonstrate that eliminating hepatitis C virus (HCV) in the United States (US) heavily depends on treating incarcerated persons. Knowing the scope of the carceral HCV epidemic by state will help guide national elimination efforts.
Methods
Between 2019 and 2023, all state prison systems received surveys requesting data on hepatitis C antibody and viremic prevalence. We supplemented survey information with publicly available HCV data to corroborate responses and fill in data gaps.
Results
Weighting HCV prevalence by state prison population size, we estimate that 15.2% of the US prison population is HCV seropositive and 8.7% is viremic; 54.9% of seropositive persons have detectable RNA. Applying prevalence estimates to the total prison population at year-end 2021, 91 090 persons with HCV infection resided in a state prison.
Conclusions
With updated and more complete HCV data from all 50 states, HCV prevalence in state prisons is nearly 9-fold higher than the US general population. The heterogeneity in HCV prevalence by state prison system may reflect variable exposure before arrest and/or differences in treatment availability during incarceration. Elimination of HCV in the country depends on addressing the carceral epidemic, and one of the first steps is understanding the size of the problem.
Топ-30
Журналы
|
1
2
3
|
|
|
Journal of Viral Hepatitis
3 публикации, 17.65%
|
|
|
Clinical Infectious Diseases
2 публикации, 11.76%
|
|
|
Research and Practice in Thrombosis and Haemostasis
1 публикация, 5.88%
|
|
|
Emerging Infectious Diseases
1 публикация, 5.88%
|
|
|
Hepatology
1 публикация, 5.88%
|
|
|
Journal of Correctional Health Care
1 публикация, 5.88%
|
|
|
JAMA - Journal of the American Medical Association
1 публикация, 5.88%
|
|
|
The Lancet Regional Health - Western Pacific
1 публикация, 5.88%
|
|
|
Current Hepatology Reports
1 публикация, 5.88%
|
|
|
International Journal of Drug Policy
1 публикация, 5.88%
|
|
|
Cureus
1 публикация, 5.88%
|
|
|
BMJ Open
1 публикация, 5.88%
|
|
|
Singapore Medical Journal
1 публикация, 5.88%
|
|
|
The Lancet Infectious Diseases
1 публикация, 5.88%
|
|
|
1
2
3
|
Издатели
|
1
2
3
4
|
|
|
Elsevier
4 публикации, 23.53%
|
|
|
Wiley
3 публикации, 17.65%
|
|
|
Springer Nature
2 публикации, 11.76%
|
|
|
Oxford University Press
2 публикации, 11.76%
|
|
|
Centers for Disease Control and Prevention (CDC)
1 публикация, 5.88%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 публикация, 5.88%
|
|
|
Mary Ann Liebert
1 публикация, 5.88%
|
|
|
American Medical Association (AMA)
1 публикация, 5.88%
|
|
|
BMJ
1 публикация, 5.88%
|
|
|
Singapore Medical Association
1 публикация, 5.88%
|
|
|
1
2
3
4
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.